V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217853 | 20131475 | 1.75 | 67.5 | Palliative (P) | 2018-04-29 | 2018-09-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100842418 |
| 20217854 | 20131476 | 0 | 72.9 | Palliative (P) | 2019-03-21 | 2019-03-23 | null | N | N | LANREOTIDE | 100959687 |
| 20217859 | 20131477 | 0 | null | Curative (C) | 2016-04-05 | 2016-04-08 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101433099 |
| 20217861 | 20131478 | 0 | null | null | 2016-12-19 | 2016-12-22 | null | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101601494 |
| 20217864 | 20131479 | 0 | 72.3 | Palliative (P) | 2017-12-19 | 2018-01-16 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | HCX | 101469844 |
| 20217867 | 20131480 | 0 | 80.9 | 03 | 2017-07-17 | 2017-08-11 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 101100154 |
| 20217868 | 20131481 | 0 | 51.8 | null | 2017-08-02 | 2017-08-02 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101219182 |
| 20217869 | 20131482 | 0 | 109.5 | Palliative (P) | 2020-01-02 | 2020-01-10 | null | 02 | N | DOXORUBICIN EMBOLISATION | 100204204 |
| 20217872 | 20131483 | 0 | 57 | null | null | 2018-04-11 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101405600 |
| 20217873 | 20131484 | 0 | null | null | 2018-07-17 | 2018-08-14 | LANREOTIDE | 02 | null | LANREOTIDE | 100795499 |
| 20217886 | 20131485 | 0 | 107 | 03 | 2018-11-04 | 2018-12-05 | Capecitabine + Mitomycin | null | N | CAPECITABINE + MITOMYCIN | 100373049 |
| 20217887 | 20131486 | 0 | 101 | null | null | 2016-04-09 | null | 02 | null | DOXORUBICIN EMBOLISATION | 100091340 |
| 20217891 | 20131487 | 0 | 57 | Palliative (P) | 2019-03-02 | 2019-03-04 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + MITOMYCIN | 101507979 |
| 20217893 | 20131488 | 0 | 67 | null | 2018-12-24 | 2019-01-16 | HCX | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101581434 |
| 20217895 | 20131489 | 0 | 61.6 | Palliative (P) | 2019-06-10 | 2019-06-25 | null | null | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100703538 |
| 20217899 | 20131490 | 0 | null | null | 2019-03-30 | 2019-03-31 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100083245 |
| 20217911 | 20131491 | 0 | 87.25 | Curative (C) | 2018-12-08 | 2019-05-02 | Capecitabine + Mitomycin | 02 | Y | CAPECITABINE + MITOMYCIN | 100209678 |
| 20217912 | 20131492 | 0 | null | Palliative (P) | 2019-08-22 | 2020-01-04 | Capecitabine + Mitomycin | 02 | N | CAPECITABINE + MITOMYCIN | 101453783 |
| 20217913 | 20131493 | 0 | 0 | Palliative (P) | null | 2018-01-23 | HCX | 02 | N | DOXORUBICIN EMBOLISATION | 100792944 |
| 20217918 | 20131494 | 0 | 84.4 | Neo-adjuvant (N) | 2020-07-06 | 2020-08-04 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100381682 |
| 20217924 | 20131496 | null | null | Palliative (P) | null | 2018-02-06 | null | null | N | CARBOPLATIN + GEMCITABINE | 100222873 |
| 20217941 | 20131498 | null | null | Adjuvant (A) | null | 2016-04-15 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101585010 |
| 20217948 | 20131500 | null | null | null | null | 2017-08-09 | null | null | null | CARBOPLATIN + GEMCITABINE | 101581186 |
| 20217952 | 20131501 | null | null | null | null | 2018-10-06 | null | null | null | IMATINIB | 100406789 |
| 20217960 | 20131503 | null | null | null | null | 2017-02-02 | null | null | null | CARBOPLATIN + GEMCITABINE | 100048402 |
| 20217962 | 20131504 | null | null | null | null | 2019-02-28 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100954407 |
| 20217978 | 20131506 | null | null | null | 2018-03-27 | 2018-04-08 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 101677082 |
| 20217980 | 20131507 | 1.6 | 83.8 | Palliative (P) | null | 2018-10-29 | null | null | N | REGORAFENIB | 100277074 |
| 20217985 | 20131508 | null | null | Palliative (P) | null | 2016-03-21 | null | null | N | REGORAFENIB | 101670572 |
| 20217986 | 20131509 | null | null | null | null | 2019-09-05 | Carboplatin AUC 2 - 5 | N | null | CARBOPLATIN | 100589847 |
| 20217989 | 20131511 | null | null | null | null | 2017-05-05 | null | null | null | CARBOPLATIN + GEMCITABINE | 101038346 |
| 20217992 | 20131512 | null | null | Curative (C) | null | 2018-12-17 | null | null | Y | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101860127 |
| 20217993 | 20131513 | null | null | Palliative (P) | 2018-04-01 | 2018-04-06 | null | null | N | CARBOPLATIN | 100754645 |
| 20217995 | 20131514 | null | null | Curative (C) | null | 2018-08-08 | CARBOPLATIN + GEMCITABINE | 02 | y | CARBOPLATIN + GEMCITABINE | 100770145 |
| 20217996 | 20131515 | null | null | Palliative (P) | null | 2019-03-14 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101739847 |
| 20218013 | 20131518 | null | null | Palliative (P) | 2018-05-16 | 2018-05-22 | Imatinib 400mg | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100481869 |
| 20218016 | 20131519 | null | null | null | null | 2016-05-30 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 100474721 |
| 20218020 | 20131520 | null | null | Palliative (P) | 2019-07-22 | 2019-07-24 | null | null | null | FLUOROURACIL + MITOMYCIN + RT | 100626427 |
| 20218023 | 20131521 | null | null | null | null | 2017-08-24 | null | null | null | CARBOPLATIN | 101603957 |
| 20218024 | 20131522 | 1.65 | 60 | Adjuvant (A) | null | 2016-10-05 | CAPECITABINE + TEMOZOLOMIDE | N | N | CAPECITABINE + TEMOZOLOMIDE | 101206442 |
| 20218026 | 20131523 | null | null | null | 2018-08-22 | 2018-08-22 | CAPECITABINE + TEMOZOLOMIDE | 02 | null | CAPECITABINE + TEMOZOLOMIDE | 100508900 |
| 20218027 | 20131524 | 1.73 | 87.5 | Palliative (P) | null | 2018-06-04 | null | null | N | IMATINIB | 100360702 |
| 20218029 | 20131526 | null | 105.6 | null | null | 2017-05-07 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101426410 |
| 20218033 | 20131528 | null | null | Palliative (P) | 2018-05-08 | 2018-06-03 | null | null | N | CETUXIMAB + OXALIPLATIN + MDG | 101396744 |
| 20218041 | 20131529 | null | null | null | null | 2019-11-03 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100077798 |
| 20218042 | 20131530 | 1.7 | 87 | null | 2019-08-12 | 2019-08-12 | IMATINIB | 02 | null | IMATINIB | 100680032 |
| 20218046 | 20131531 | null | null | Palliative (P) | null | 2018-12-19 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100747534 |
| 20218055 | 20131533 | null | null | null | null | 2019-05-27 | null | null | null | PLATFORM TRIAL | 101065960 |
| 20218056 | 20131534 | 1.57 | 81.7 | null | 2018-10-13 | 2018-10-24 | null | null | null | CETUXIMAB + OXALIPLATIN + MDG | 101026700 |
| 20218059 | 20131535 | 1.75 | 57.8 | Palliative (P) | null | 2016-12-24 | null | null | N | RALTITREXED | 100628636 |